ARA-290
Buy NowAlso known as: Cibinetide, Helix B Surface Peptide
Overview
ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from erythropoietin (EPO). It provides tissue-protective and anti-inflammatory effects without stimulating red blood cell production, making it safer than EPO for regenerative applications.
How It Works
ARA-290 selectively activates the innate repair receptor (IRR), a heterodimer of the EPO receptor and β-common receptor (CD131). This triggers tissue-protective signaling without stimulating red blood cell production, providing the regenerative benefits of EPO safely.
Research Status
Phase 2/3 clinical trials for neuropathy. Orphan drug designation for sarcoidosis. Not yet FDA approved.
Purchase ARA-290
Get high-quality, research-grade ARA-290 from our trusted partner.
Shop at ChampionPeptidesRelated Peptides
BPC-157
BPC-157 is a synthetic peptide derived from a protein found in stomach acid. It's known for its remarkable healing properties, particularly for muscles, tendons, and the digestive system.
LL-37
LL-37 is the only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide derived from hCAP18. It exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi while modulating immune responses and promoting wound healing.
Related Peptides
BPC-157
BPC-157 is a synthetic peptide derived from a protein found in stomach acid. It's known for its remarkable healing properties, particularly for muscles, tendons, and the digestive system.
LL-37
LL-37 is the only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide derived from hCAP18. It exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi while modulating immune responses and promoting wound healing.